Skip to content

Efficacy and Safety of Ultrasound-guided Acupotomy Intervention with Myofascial Trigger Points in the Treatment of Thoracodorsal Myofascial Pain Syndrome: a Prospective Randomized Controlled Trial

Study on the clinical diagnosis and treatment protocol and mechanism of action of visual acupuncture release in the treatment of chronic pain of thoracodal myofasciitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001450
Enrollment
Unknown
Registered
2025-07-20
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracodorsal Myofascial Pain Syndrome

Interventions

Control subjects:Ordinary Acupotomy
Observation Group:Ultrasound-Guided Acupotomy

Sponsors

The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) The above diagnostic criteria are met; 2) The main manifestation is back pain which may occur in the back of the shoulders and the chest and back; 3)The duration of the disease is 3 months or more; 4) Age: 20-70 years old both male and female; 5) Not using any other treatment or taking medication in the last 2 weeks; 6)Voluntary participation in this study and signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1)Patients with skin allergies or who are unable to complete the needle knife treatment; 2) Women who are pregnant or breastfeeding; 3)Patients with skin infection or severe ulceration at the site of surgery; 4)Patients with heart disease or other symptoms in the heart and chest; 5) Diabetic patients with uncontrolled blood sugar; 6) Patients with severe chronic diseases that are life-threatening and patients with mental disorders that prevent them from participating in the procedure; 7) Patients with hemophilia or thrombocytopenic purpura or bleeding tendency.

Design outcomes

Primary

MeasureTime frame
Visual analog scoring method;

Secondary

MeasureTime frame
enzyme-linked immunosorbent assay (ELISA) ;Oswestry disability index,ODI;Pittsburgh Sleep Quality Index Assessment;

Countries

China

Contacts

Public ContactJunchen Zhu

The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine

2006zhujc@163.com+86 139 6506 7700

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026